Verastem (VSTM) stock receives a "Buy" rating, driven by progress in KRAS G12D-targeted therapies and multiple 2026 catalysts. Read the full analysis here.

Researchers have identified a specific hormone produced by pancreatic beta cells as a direct driver of obesity-linked pancreatic cancer in mouse models, shifting scientific attention away from insulin ...

Last month, the United States Food and Drug Administration (FDA) approved a new wearable device for treating pancreatic cancer. This device, called Optune | Cancer ...

Obesity is known to increase the risk of many serious diseases, including diabetes, heart disease, and certain types of ...

Obesity increases the body's need for insulin, forcing cells in the pancreas known as beta cells to ramp up insulin ...

DOC1021 is a first-in-class, patient-derived double-loaded dendritic cell therapy that combines tumor lysate and amplified tumor-derived mRNA. The immunotherapy is made with a patient's dendritic ...

Around 200 million animals are used in lab research around the world each year. Organoids may one day replace them.

Cancer Surgeons at Manipal Hospitals, Pune, successfully removed a rare pancreatic tumour in a 10-year-old girl, marking one of the youngest reported cases of Solid Pseudopapillary Neoplasm (SPN) of ...

A birthing room at the hospital has been named in her honour and now her sister is taking on a fundraising challenge ...

Mom’s cancer is back and “her refusal to face what is likely to be the end of her life” is stressing the letter writer out.

Pancreatic cancer is widely known as one of the most dangerous and difficult cancers to treat. Among the different types of pancreatic cancer, the most common and aggressive form is called pancreatic ...

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...